These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 12202468)

  • 41. Pharmacological management of osteoporosis in postmenopausal women: a comparative review.
    Reid IR
    Drugs Aging; 1999 Nov; 15(5):349-63. PubMed ID: 10600043
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Non-responders to hormone replacement therapy for the prevention of postmenopausal bone loss: do they exist?
    Hassager C; Jensen SB; Christiansen C
    Osteoporos Int; 1994 Jan; 4(1):36-41. PubMed ID: 8148570
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An economic analysis of hormone replacement therapy for the prevention of fracture in young postmenopausal women.
    Lamy O; Krieg MA; Burckhardt P; Wasserfallen JB
    Expert Opin Pharmacother; 2003 Sep; 4(9):1479-88. PubMed ID: 12943477
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A systematic review of the skeletal effects of estrogen therapy in postmenopausal women. II. An assessment of treatment effects.
    O'Connell D; Robertson J; Henry D; Gillespie W
    Climacteric; 1998 Jun; 1(2):112-23. PubMed ID: 11907914
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effectiveness of bone density measurement and associated treatments for prevention of fractures. An international collaborative review.
    Hailey D; Sampietro-Colom L; Marshall D; Rico R; Granados A; Asua J
    Int J Technol Assess Health Care; 1998; 14(2):237-54. PubMed ID: 9611900
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A systematic review of the skeletal effects of estrogen therapy in postmenopausal women. I. An assessment of the quality of randomized trials published between 1977 and 1995.
    Henry D; Robertson J; O'Connell D; Gillespie W
    Climacteric; 1998 Jun; 1(2):92-111. PubMed ID: 11907921
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Initiation of hormone replacement therapy after diagnosis of osteoporosis by bone densitometry.
    Phillipov G; Mos E; Scinto S; Phillips PJ
    Osteoporos Int; 1997; 7(2):162-4. PubMed ID: 9166398
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hormone replacement therapy for postmenopausal osteoporosis.
    Cranney A; Wells GA
    Clin Geriatr Med; 2003 May; 19(2):361-70. PubMed ID: 12916291
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phytotherapy versus hormonal therapy for postmenopausal bone loss: a meta-analysis.
    Xu M; Qi C; Deng B; Deng PX; Mo CW
    Osteoporos Int; 2009 Apr; 20(4):519-26. PubMed ID: 18797814
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Prevention of osteoporosis: estrogen substitution paradigm].
    Lange S; Paesler E; Richter K
    Gesundheitswesen; 1996 Feb; 58(2):111-4. PubMed ID: 8881083
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Natural health products in the prevention and treatment of osteoporosis: systematic review of randomized controlled trials.
    Whelan AM; Jurgens TM; Bowles SK
    Ann Pharmacother; 2006 May; 40(5):836-49. PubMed ID: 16670364
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of progestins with different glucocorticoid activity on bone metabolism.
    Ishida Y; Mine T; Taguchi T
    Clin Endocrinol (Oxf); 2008 Mar; 68(3):423-8. PubMed ID: 17973947
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Testosterone use in men and its effects on bone health. A systematic review and meta-analysis of randomized placebo-controlled trials.
    Tracz MJ; Sideras K; Boloña ER; Haddad RM; Kennedy CC; Uraga MV; Caples SM; Erwin PJ; Montori VM
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2011-6. PubMed ID: 16720668
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of hormone replacement therapy on intervertebral disc height.
    Stevenson TEJ; Brincat MP; Pollacco J; Stevenson JC
    Climacteric; 2023 Apr; 26(2):110-113. PubMed ID: 36626929
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-osteoporosis treatments changed body composition in postmenopausal women: A systematic review and meta-analysis.
    Shi L; Xu X; Xiang G; Duan S
    Medicine (Baltimore); 2022 Sep; 101(36):e30522. PubMed ID: 36086691
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hormone replacement therapy and prevention of osteoporosis: risk assessment and practical advice.
    Balogh A; Bettembuk P
    Eur J Obstet Gynecol Reprod Biol; 1997 Feb; 71(2):189-91. PubMed ID: 9138964
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Randomized trial of osteoporosis screening. Use of hormone replacement therapy and quality-of-life results.
    Torgerson DJ; Thomas RE; Campbell MK; Reid DM
    Arch Intern Med; 1997 Oct; 157(18):2121-5. PubMed ID: 9382669
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hormonal replacement therapy and the skeletal system.
    Christiansen C; Riis BJ
    Maturitas; 1990 Sep; 12(3):247-57. PubMed ID: 2215270
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The pathophysiology and treatment of postmenopausal osteoporosis. An evidence-based approach to estrogen replacement therapy.
    Rosen CJ; Kessenich CR
    Endocrinol Metab Clin North Am; 1997 Jun; 26(2):295-311. PubMed ID: 9193885
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.